UBC PiMS Research Group (the Tremlett Laboratory)
Pharmacoepidemiology in Multiple Sclerosis Research Group (the Tremlett Laboratory)


2023 October. The European Committee for Treatment and Research in MS Congress (9th Joint ECTRIMS-ACTRIMS Meeting, Milan, Italy)


Himali Bergeron-Vitez
October 2023: Poster Presentation
P444: Gabapentinoid and anticonvulsant pharmacotherapy in the multiple sclerosis prodrome: a population-based matched cohort study
The Prodomic Phase

Invited by the MSMilan2023 Scientific Programme Committee to actively participate as a faculty member and speak (one of three faculty) at: the ‘Hot Topics’ session 8: Prodromic MS – can we reduce the risk of MS conversion?
>8,700 attendees from >100 countries

a place of mind, The University of British Columbia

Pharmacoepidemiology in MS (PiMS)
2211 Wesbrook Mall,
Vancouver, BC, V6T 2B5, Canada

Emergency Procedures | Accessibility | Contact UBC  | © Copyright The University of British Columbia